Full View

Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release: Endothelial β2-Adrenergic Receptor–Mediated Nitric Oxide Production

MAW Broeders, PA Doevendans, BCAM Bekkers… - Circulation, 2000 - Am Heart Assoc
Background—Nebivolol is a β1-selective adrenergic receptor antagonist with proposed nitric
oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether …
被引用次数：342 相关文章
[PDF] researchgate.net

[PDF][PDF] Nebivolol: A Third-Generation ß-Blocker That Augments Vascular Nitric Oxide Release

MAW Broeders, PA Doevendans, BCAM Bekkers… - 2000 - researchgate.net
Background—Nebivolol is a ß1-selective adrenergic receptor antagonist with proposed nitric
oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether …
[PDF] academia.edu

[PDF][PDF] Nebivolol: A Third-Generation ß-Blocker That Augments Vascular Nitric Oxide Release

MAW Broeders, PA Doevendans, BCAM Bekkers… - 2000 - academia.edu
Background—Nebivolol is a ß1-selective adrenergic receptor antagonist with proposed nitric
oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether …

Nebivolol: A Third-Generation β-Blocker That Augments Vascular Nitric Oxide Release

MAW Broeders, PA Doevendans, BCAM Bekkers… - Circulation, 2000 - cir.nii.ac.jp
抄録< jats: p>< jats: italic> Background</jats: italic>—Nebivolol is a β< jats: sub> 1</jats:
sub>-selective adrenergic receptor antagonist with proposed nitric oxide (NO)–mediated …

[引用][C] Nebivolol: a third-generation-blocker that augments vascular nitric oxide release endothelial-adrenergic receptormediated nitric oxide production

MAW Broeders, PA Doevendans… - … .-New York, NY, 2000 - repository.uantwerpen.be
Nebivolol: a third-generation &# x3C; script type= &# x22; math/tex&# x22; &# x3E;\beta&#
x3C;/script&# x3E;-blocker that augments vascular nitric oxide release endothelial &# x3C; …

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta (2)-adrenergic receptor-mediated nitric oxide production.

MA Broeders, PA Doevendans, BC Bekkers… - Circulation, 2000 - europepmc.org
Background Nebivolol is a beta (1)-selective adrenergic receptor antagonist with proposed
nitric oxide (NO)-mediated vasodilating properties in humans. In this study, we explored …

[引用][C] Nebivolol: A third-generation β-blocker that augments vascular nitric oxide release: Endothelial β2-Adrenergic receptor-mediated nitric oxide production

MAW BROEDERS, PA DOEVENDANS… - … (New York, NY), 2000 - pascal-francis.inist.fr
Nebivolol : A third-generation β-blocker that augments vascular nitric oxide release : Endothelial
β2-Adrenergic receptor-mediated nitric oxide production CNRS Inist Pascal-Francis CNRS Pascal …
[PDF] psu.edu

[PDF][PDF] Nebivolol: A Third-Generation ß-Blocker That Augments Vascular Nitric Oxide Release

MAW Broeders, PA Doevendans, BCAM Bekkers… - 2000 - Citeseer
Background—Nebivolol is a ß1-selective adrenergic receptor antagonist with proposed nitric
oxide (NO)–mediated vasodilating properties in humans. In this study, we explored whether …

Nebivolol: A Third-Generation beta-Blocker That Augments Vascular Nitric Oxide Release: Endothelial beta (2)-Adrenergic Receptor-Mediated Nitric Oxide Production …

MAW Broeders, PA Doevendans, B Bekkers… - …, 2000 - cris.maastrichtuniversity.nl
Background-Nebivolol is a beta-selective adrenergic receptor antagonist with proposed
nitric oxide (NO)-mediated vasodilating properties in humans. In this study, we explored …

Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta (2)-adrenergic receptor-mediated nitric oxide production

MA Broeders, PA Doevendans, BC Bekkers… - …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Nebivolol is a beta (1)-selective adrenergic receptor antagonist with proposed
nitric oxide (NO)-mediated vasodilating properties in humans. In this study, we explored …